Eurobio Scientific finalizes the acquisition of CareDX’s transplant Lab Product division
Acceleration of Eurobio’s strategic plan to become an in-vitro molecular diagnostics (“IVD”) leader
July 1, 2026
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
Acceleration of Eurobio’s strategic plan to become an in-vitro molecular diagnostics (“IVD”) leader